DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Healthcare
Updated 1m ago
EMO logo

EM Systems Co., Ltd.DB:EMO Stock Report

Market Cap €230.9m
Updated 1m ago
Share Price
n/a
1Y-25.1%
7D0%
1D-1.2%
Portfolio Value
​
View

EM Systems Co., Ltd.

DB:EMO Stock Report

Market Cap: €230.9m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

EM Systems (EMO) Stock Overview

Develops, sells, and maintains various IT systems for pharmacies, clinics, and care/welfare other business in Japan. More details

EMO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance1/6
Financial Health5/6
Dividends2/6

Rewards

Price-To-Earnings ratio (27.5x) is below the Healthcare Services industry average (28x)

Earnings are forecast to grow 12.69% per year

Risk Analysis

Dividend of 3.83% is not well covered by earnings or free cash flows

Large one-off items impacting financial results

Profit margins (6.9%) are lower than last year (11.7%)


EMO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW431,284 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
431,284 investors already sharing narratives
€
Current Price
€3.225.2% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture029b2016201920222025202620282031Revenue JP¥28.7bEarnings JP¥2.0b
Advanced
View all narratives

EM Systems Co., Ltd. Competitors

DocCheck

Symbol: XTRA:AJ91
Market cap: €56.3m

CompuGroup Medical SE KGaA

Symbol: HMSE:COP
Market cap: €1.4b

MeVis Medical Solutions

Symbol: XTRA:M3V
Market cap: €42.6m

ifa systems

Symbol: HMSE:IS8
Market cap: €6.3m

Price History & Performance

Summary of share price highs, lows and changes for EM Systems
Historical stock prices
Current Share PriceJP¥3.22
52 Week HighJP¥4.56
52 Week LowJP¥2.52
Beta0.26
1 Month Change0.63%
3 Month Change25.78%
1 Year Change-25.12%
3 Year Change-30.60%
5 Year Change-48.48%
Change since IPO68.92%

Recent News & Updates

Recent updates

Shareholder Returns

EMODE Healthcare ServicesDE Market
7D0%-2.1%-0.6%
1Y-25.1%8.7%4.0%

Return vs Industry: EMO underperformed the German Healthcare Services industry which returned 7.3% over the past year.

Return vs Market: EMO underperformed the German Market which returned 3.4% over the past year.

Price Volatility

Is EMO's price volatile compared to industry and market?
EMO volatility
EMO Average Weekly Movement3.0%
Healthcare Services Industry Average Movement5.6%
Market Average Movement5.0%
10% most volatile stocks in DE Market11.7%
10% least volatile stocks in DE Market2.4%

Stable Share Price: EMO has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: EMO's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980858Hiromasa Kunimitsuwww.emsystems.co.jp

EM Systems Co., Ltd., together with its subsidiaries, develops, sells, and maintains various IT systems for pharmacies, clinics, and care/welfare other business in Japan. The company operates through Dispensing Systems Business, Medical Systems Business, Nursing Care/Welfare System Business, and Other Business segments. It develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; IT systems for clinics, including medical accounting and electronic medical record systems; and office processing systems for care/welfare providers.

EM Systems Co., Ltd. Fundamentals Summary

How do EM Systems's earnings and revenue compare to its market cap?
EMO fundamental statistics
Market cap€230.87m
Earnings (TTM)€8.40m
Revenue (TTM)€121.89m
27.5x
P/E Ratio
1.9x
P/S Ratio

Is EMO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EMO income statement (TTM)
RevenueJP¥21.94b
Cost of RevenueJP¥11.25b
Gross ProfitJP¥10.69b
Other ExpensesJP¥9.18b
EarningsJP¥1.51b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 13, 2026

Earnings per share (EPS)21.83
Gross Margin48.72%
Net Profit Margin6.89%
Debt/Equity Ratio2.0%

How did EMO perform over the long term?

See historical performance and comparison

Dividends

3.8%
Current Dividend Yield
124%
Payout Ratio

Does EMO pay a reliable dividends?

See EMO dividend history and benchmarks
When do you need to buy EMO by to receive an upcoming dividend?
EM Systems dividend dates
Ex Dividend DateDec 29 2026
Dividend Pay DateMar 30 2027
Days until Ex dividend98 days
Days until Dividend pay date189 days

Does EMO pay a reliable dividends?

See EMO dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 15:42
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EM Systems Co., Ltd. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masatoshi NagataIchiyoshi Research Institute Inc.
Shigekazu IshidaMarusan Securities Co. Ltd.
Shigeo MutoSMBC NIKKO

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide